Skip to content
DataLookout
Menu

Yale University clinical trial pipeline

Get alerts when Yale University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

28 trials changed in the last 30 days: 2 stopped, 15 with notable changes, 11 with minor changes only.

  1. Notable: Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans Enrollment reduced: 30 → 10 participants Yale UniversityPhase 1 NCT04711915
  2. Notable: STAY · Strategic Treatment and Assessment for Youth Primary and study completion pushed from Nov 30, 2026 to Nov 30, 2027 Yale UniversityNot applicable NCT06515236
  3. Minor: RS-ART · Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART) Enrollment increased: 135 → 180 participants Yale UniversityNot applicable NCT06541028
  4. Notable: Probing the Cannabinoid System · a Family History of Psychosis Primary completion pushed from Jun 2026 to Jun 2028 Yale UniversityEarly Phase 1 NCT02102113
  5. Notable: Economics of Domestic Violence: Evidence From Bangladesh Primary and study completion pushed from Dec 2025 to Jul 2027 Yale UniversityNot applicable NCT06916377
  6. Notable: Systems Investigation of Vaccine Responses in Aging and Frailty Primary and study completion pushed from Apr 2027 to May 2029 Yale UniversityPhase 2 NCT05291676
  7. Notable: Overdiagnosis and Breast Cancer Screening Decisions Results posted: Nov 9, 2026 Yale UniversityNot applicable NCT07071415
  8. Stopped: HARP · Off-Label Medications for Alcohol Use Disorder · HIV: Pilot Study 2 Trial terminated Yale UniversityPhase 2 NCT06006143
  9. Notable: Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery Recruitment opened Yale UniversityPhase 2 NCT07730294
  10. Notable: SAMU · Syndemic Adapted Medly Uganda Recruitment opened Yale UniversityNot applicable NCT07525271
  11. Minor: Psilocybin - Induced Neuroplasticity · Major Depressive Disorder Study completion pushed from Sep 2026 to Dec 2026 Yale UniversityPhase 1 NCT03554174
  12. Notable: Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images Primary and study completion pushed from Jul 2026 to May 2027 Yale UniversityNot specified NCT07228429
  13. Notable: SEMA AUD · Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes Recruitment opened Yale UniversityPhase 1 NCT07772960
  14. Minor: SV2A Density Cannabis Use Disorder Trial completed Yale UniversityEarly Phase 1 NCT05472818
  15. Minor: PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults Trial completed Yale UniversityEarly Phase 1 NCT05906511
  16. Minor: Recovery Finance: Financial Health and Mental Health After Incarceration Trial completed Yale UniversityNot applicable NCT06914856
  17. Notable: Developing a Novel Human Laboratory Paradigm for AUD Medication Screening Primary and study completion pushed from Aug 31, 2026 to Aug 31, 2027 Yale UniversityNot applicable NCT06489782
  18. Minor: Intradermal Influenza Vaccination- Healthy Cohort Trial completed Yale UniversityEarly Phase 1 NCT06067555
  19. Stopped: Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes Trial terminated Yale UniversityNot applicable NCT05743868
  20. Notable: Text2Quit · Adaptation and Testing of a Novel Text-based Tobacco Cessation and Education Intervention in Kenyan Emergency Department Patients Recruitment opened Yale UniversityNot applicable NCT07734727
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-17 NCT07941895 Biphasic Effect of Alcohol on Pain Phase 2 Not Yet Recruiting
2026-11-13 NCT07934784 The Mother-infant Touch Study Not Yet Recruiting
2026-11-12 NCT07933484 DECISIVE Tool Pilot Trial Not Yet Recruiting
2026-11-06 NCT07920874 Financial Tools Access and Navigation (FinTAN) Not Yet Recruiting
2026-11-05 NCT07920588 STRONG: SMART Trial Not Yet Recruiting
2026-11-04 NCT07915323 PET Imaging of the sigma1 Receptor in Healthy Adults Phase 1 Recruiting
2026-11-04 NCT07915986 Brain Dopamine Dynamics in Obesity Phase 1 Not Yet Recruiting
2026-11-04 NCT07916974 Parent-Based Intervention for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID) Not Yet Recruiting
2026-11-02 NCT07908329 Intradermal Influenza Vaccination Early Phase 1 Recruiting
2026-11-02 NCT07910565 Prospective Study to Evaluate the Clinical Utility of ctDNA Tumor Fraction (TF) for… Not Yet Recruiting

Active trials by phase

Early Phase 1
14
Phase 1
40
Phase 1/2
7
Phase 2
63
Phase 2/3
1
Phase 3
10
Phase 4
11
Not charted: 214 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 57

Get alerts when Yale University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free